š”š²šš š¦ššŗšŗš®šæš
ā¢ Lupin has tied up with Amman Pharma to market a biosimilar product in the Middle East region.
ā¢ The company has inked a licensing pact for the commercialisation and marketing of Ranibizumab, a biosimilar of Lucentis, in various countries including Saudi Arabia, UAE, Iraq and Lebanon.
ā¢ Ranibizumab is indicated for the treatment of various eye conditions, including age-related macular degeneration and diabetic macular edema.